Zhiqiang Hu

机构：Sun Yat-sen University, Peking University, Fudan University, Peking University Cancer Hospital, Zhongshan Hospital, The First Affiliated Hospital, Sun Yat-sen University, Beijing Academy of Quantum Information Sciences, State Key Laboratory of Low-Dimensional Quantum Physics, Newcastle University, Tsinghua University · ORCID：0000-0001-8854-3410

发表论文 369 篇 · 总被引 10600 次 · h-index 44

代表论文

• Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study (2025 · The Lancet Oncology · 被引 20)
• Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma (2026 · New England Journal of Medicine · 被引 14)
• Structural and electronic signatures of strain-tunable marginally twisted bilayer graphene (2025 · National Science Review · 被引 4)
• Norepinephrine promotes tumour cell aggressiveness and NK cell ferroptosis via ADRB2 in intrahepatic cholangiocarcinoma with perineural invasion (2026 · Gut · 被引 3)
• Macrophage PD-1 regulates energy expenditure and metabolic dysfunction under immune checkpoint blockade (2025 · Cell Metabolism · 被引 2)
• Nuclear binding SET domain 1 alleviates cartilage ferroptosis in knee osteoarthritis by upregulating the krüppel‐like factor 9/autophagy‐related 14 pathway via H3K36me2 modification (2025 · Journal of Cell Communication and Signaling · 被引 2)